Financial Ratios Coca-Cola Europacific Partners plc
Equities
CCEP
GB00BDCPN049
Non-Alcoholic Beverages
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.00 EUR | -0.88% |
|
-2.83% | +1.94% |
| 05-12 | Coca-Cola Europacific Partners PLC - Special Call | |
| 04-29 | UBS Adjusts Price Target on Coca-Cola Europacific Partners to $109 From $107, Maintains Buy Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.11 | 4.59 | 5.02 | 5.4 | 5.72 | |||||
Return on Total Capital | 5.9 | 6.72 | 7.54 | 8.16 | 8.82 | |||||
Return On Equity % | 14.93 | 20.75 | 21.64 | 17.03 | 22.89 | |||||
Return on Common Equity | 15.04 | 20.83 | 21.64 | 17.22 | 23.79 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.49 | 35.98 | 36.75 | 35.63 | 35.58 | |||||
SG&A Margin | 25.95 | 23.59 | 23.99 | 22.88 | 22.24 | |||||
EBITDA Margin % | 15.23 | 15.47 | 15.74 | 15.85 | 16.39 | |||||
EBITA Margin % | 11.64 | 12.49 | 13.1 | 13.12 | 13.54 | |||||
EBIT Margin % | 11.54 | 12.39 | 12.86 | 12.76 | 13.34 | |||||
Income From Continuing Operations Margin % | 7.18 | 8.78 | 9.12 | 7.07 | 9.47 | |||||
Net Income Margin % | 7.14 | 8.71 | 9.12 | 6.94 | 9.29 | |||||
Net Avail. For Common Margin % | 7.14 | 8.71 | 9.12 | 6.94 | 9.29 | |||||
Normalized Net Income Margin | 6.59 | 7.2 | 7.57 | 7.25 | 7.49 | |||||
Levered Free Cash Flow Margin | 6.51 | 13.26 | 9.23 | 9.3 | 8.36 | |||||
Unlevered Free Cash Flow Margin | 7.2 | 13.89 | 9.84 | 10.11 | 9.25 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.57 | 0.59 | 0.62 | 0.68 | 0.69 | |||||
Fixed Assets Turnover | 3.02 | 3.32 | 3.47 | 3.47 | 3.32 | |||||
Receivables Turnover (Average Receivables) | 6.82 | 6.73 | 6.82 | 7.68 | 7.69 | |||||
Inventory Turnover (Average Inventory) | 9.36 | 8.74 | 8.46 | 8.88 | 8.54 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.95 | 0.89 | 0.91 | 0.81 | 0.8 | |||||
Quick Ratio | 0.68 | 0.65 | 0.68 | 0.57 | 0.56 | |||||
Operating Cash Flow to Current Liabilities | 0.35 | 0.4 | 0.39 | 0.38 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 53.53 | 54.25 | 53.56 | 47.66 | 47.47 | |||||
Days Outstanding Inventory (Average Inventory) | 38.99 | 41.76 | 43.13 | 41.23 | 42.76 | |||||
Average Days Payable Outstanding | 64.44 | 74.33 | 83.45 | 76.36 | 82.44 | |||||
Cash Conversion Cycle (Average Days) | 28.08 | 21.68 | 13.25 | 12.54 | 7.79 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 182.86 | 162.19 | 144.6 | 127.39 | 130 | |||||
Total Debt / Total Capital | 64.65 | 61.86 | 59.12 | 56.02 | 56.52 | |||||
LT Debt/Equity | 164.13 | 144.25 | 128.3 | 111.91 | 124.34 | |||||
Long-Term Debt / Total Capital | 58.03 | 55.02 | 52.45 | 49.21 | 54.06 | |||||
Total Liabilities / Total Assets | 75.21 | 74.59 | 72.74 | 71.11 | 72.2 | |||||
EBIT / Interest Expense | 10.38 | 12.19 | 13.15 | 9.91 | 9.39 | |||||
EBITDA / Interest Expense | 14.61 | 16.11 | 16.98 | 12.94 | 12.11 | |||||
(EBITDA - Capex) / Interest Expense | 12.33 | 13.27 | 13.23 | 9.94 | 9.58 | |||||
Total Debt / EBITDA | 5.9 | 4.26 | 3.79 | 3.36 | 3 | |||||
Net Debt / EBITDA | 5.24 | 3.65 | 3.12 | 2.86 | 2.73 | |||||
Total Debt / (EBITDA - Capex) | 6.99 | 5.17 | 4.87 | 4.38 | 3.79 | |||||
Net Debt / (EBITDA - Capex) | 6.21 | 4.43 | 4.01 | 3.72 | 3.45 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 29.77 | 25.84 | 5.67 | 11.67 | 2.27 | |||||
Gross Profit, 1 Yr. Growth % | 35.9 | 20.78 | 7.93 | 8.2 | 2.1 | |||||
EBITDA, 1 Yr. Growth % | 60.24 | 17.45 | 7.58 | 12.27 | 5.71 | |||||
EBITA, 1 Yr. Growth % | 81.84 | 21.1 | 10.86 | 11.61 | 5.56 | |||||
EBIT, 1 Yr. Growth % | 81.9 | 21.04 | 9.7 | 10.56 | 6.94 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 98.39 | 53.95 | 9.73 | -13.48 | 37.05 | |||||
Net Income, 1 Yr. Growth % | 97.19 | 53.56 | 10.68 | -15.04 | 36.95 | |||||
Normalized Net Income, 1 Yr. Growth % | 90.84 | 22 | 11.12 | 6.63 | 5.71 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 97.25 | 53.02 | 10.33 | -15.15 | 38.27 | |||||
Accounts Receivable, 1 Yr. Growth % | 54.06 | 10.33 | -1.15 | -0.64 | 4.94 | |||||
Inventory, 1 Yr. Growth % | 69.9 | 19.27 | -1.74 | 18.58 | -3.79 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 35.96 | -0.9 | 2.75 | 20.4 | -4.34 | |||||
Total Assets, 1 Yr. Growth % | 51.22 | 0.77 | -0.2 | 6.31 | -3.95 | |||||
Tangible Book Value, 1 Yr. Growth % | 108.5 | -5.58 | -7.51 | 0.16 | 2.73 | |||||
Common Equity, 1 Yr. Growth % | 16.73 | 5.89 | 7.1 | 6.43 | -7.7 | |||||
Cash From Operations, 1 Yr. Growth % | 42.08 | 38.5 | -4.3 | 9.09 | -3.53 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.29 | 43.27 | 34.4 | 17.71 | -5.18 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 0.2 | 128.43 | -26.39 | 12.29 | -8.06 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.52 | 117.34 | -25.11 | 14.44 | -6.39 | |||||
Dividend Per Share, 1 Yr. Growth % | 64.71 | 20 | 9.52 | 7.07 | 3.55 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.02 | 27.79 | 15.32 | 8.63 | 6.86 | |||||
Gross Profit, 2 Yr. CAGR % | 5.99 | 28.11 | 14.81 | 8.01 | 5.12 | |||||
EBITDA, 2 Yr. CAGR % | -1.19 | 22.13 | 8.66 | 5.19 | 3.04 | |||||
EBITA, 2 Yr. CAGR % | 0.09 | 31.47 | 15.2 | 9.01 | 4.67 | |||||
EBIT, 2 Yr. CAGR % | 1.32 | 34.29 | 17.03 | 9.96 | 6.78 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -4.79 | 74.76 | 29.97 | -2.56 | 8.89 | |||||
Net Income, 2 Yr. CAGR % | -5.08 | 74.01 | 30.37 | -3.03 | 7.87 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0.12 | 36.3 | 18.67 | 8.68 | 4.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -3.73 | 73.73 | 29.94 | -3.24 | 8.32 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.44 | 30.38 | 4.44 | -0.89 | 2.11 | |||||
Inventory, 2 Yr. CAGR % | 26.5 | 42.35 | 8.26 | 7.95 | 6.81 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.72 | 16.08 | 0.91 | 11.22 | 7.32 | |||||
Total Assets, 2 Yr. CAGR % | 24.77 | 23.44 | 0.28 | 3 | 1.05 | |||||
Tangible Book Value, 2 Yr. CAGR % | 44.93 | 40.31 | -6.55 | -3.75 | 1.43 | |||||
Common Equity, 2 Yr. CAGR % | 6.89 | 11.18 | 6.49 | 6.77 | -0.89 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.45 | 40.28 | 15.13 | 2.18 | 2.59 | |||||
Capital Expenditures, 2 Yr. CAGR % | -16.95 | 19.87 | 38.76 | 25.78 | 5.64 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 5.54 | 45.16 | 31.99 | -9.14 | 0.02 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 5.56 | 43.12 | 29.65 | -7.47 | 1.98 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.26 | 40.59 | 14.64 | 8.29 | 5.29 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.12 | 12.96 | 19.94 | 14.09 | 6.46 | |||||
Gross Profit, 3 Yr. CAGR % | 5 | 10.71 | 21 | 12.59 | 6 | |||||
EBITDA, 3 Yr. CAGR % | 5.42 | 7.66 | 17.06 | 9.91 | 5.36 | |||||
EBITA, 3 Yr. CAGR % | 5.87 | 10.61 | 24.19 | 14.07 | 7.85 | |||||
EBIT, 3 Yr. CAGR % | 6.93 | 11.53 | 25.51 | 14.91 | 8.95 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 2.82 | 11.75 | 49.65 | 13.48 | 9.17 | |||||
Net Income, 3 Yr. CAGR % | 2.61 | 11.43 | 49.65 | 13.03 | 8.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | 6.37 | 11.12 | 27.33 | 14.6 | 7.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 4.95 | 12.35 | 49.33 | 12.73 | 8.98 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.58 | 15.02 | 18.89 | 2.72 | 1.01 | |||||
Inventory, 3 Yr. CAGR % | 18.63 | 24.05 | 25.81 | 11.6 | 3.88 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.52 | 7.34 | 11.45 | 7.03 | 5.77 | |||||
Total Assets, 3 Yr. CAGR % | 16.89 | 16.2 | 15 | 2.25 | 0.63 | |||||
Tangible Book Value, 3 Yr. CAGR % | 33.1 | 25.64 | 22.11 | -4.37 | -1.64 | |||||
Common Equity, 3 Yr. CAGR % | 2.33 | 6.55 | 9.8 | 6.47 | 1.71 | |||||
Cash From Operations, 3 Yr. CAGR % | 5.44 | 15.48 | 23.49 | 13.08 | 0.24 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.73 | -0.4 | 24.53 | 31.36 | 14.47 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -9.16 | 41.87 | 15.74 | 25.15 | -8.78 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -8.13 | 39.32 | 15.32 | 24.44 | -7.11 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.72 | 10.65 | 29.36 | 12.06 | 6.69 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.55 | 9.38 | 9.7 | 11.21 | 14.53 | |||||
Gross Profit, 5 Yr. CAGR % | 7.77 | 7.75 | 8.57 | 9.66 | 14.39 | |||||
EBITDA, 5 Yr. CAGR % | 11.86 | 9.34 | 10 | 8.58 | 13.78 | |||||
EBITA, 5 Yr. CAGR % | 12.53 | 10.66 | 12.18 | 10.9 | 17.72 | |||||
EBIT, 5 Yr. CAGR % | 13.34 | 11.29 | 12.62 | 11 | 18.56 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.47 | 17.19 | 12.92 | 5.79 | 31.78 | |||||
Net Income, 5 Yr. CAGR % | 12.33 | 16.99 | 12.92 | 5.4 | 31.28 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.07 | 11.48 | 12.97 | 10.26 | 18.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.65 | 18.47 | 14.31 | 5.83 | 31.33 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.6 | 8.37 | 8.67 | 8.37 | 11.87 | |||||
Inventory, 5 Yr. CAGR % | 11.45 | 16.25 | 14.37 | 17.34 | 17.83 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.62 | 6.27 | 6.57 | 8.88 | 9.78 | |||||
Total Assets, 5 Yr. CAGR % | 9.39 | 10.01 | 9.94 | 10.73 | 9.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | 18.87 | 18.01 | 15.54 | 12.94 | 13.38 | |||||
Common Equity, 5 Yr. CAGR % | 1.71 | 2.18 | 3.97 | 6.64 | 5.39 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.22 | 12.56 | 9.21 | 9.96 | 14.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | -5.33 | 0.65 | 5.06 | 9.35 | 16.6 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 23.65 | 21.44 | 7.17 | 18.77 | 9.91 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.87 | 20.23 | 7.09 | 18.34 | 10.48 | |||||
Dividend Per Share, 5 Yr. CAGR % | 32.72 | 14.87 | 11.66 | 9.7 | 19.14 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















